Report finds NICE’s routine appraisals need reform
A report by MAP BioPharma has found that NICE’s appraisal of rare disease medicines does not deliver equal access for patients.
Read More
Tag: reform
NHS risks losing revenue without data strategy
Think tank Reform has warned that the National Health Service risks losing out on huge potential revenue in the future if it does not put in place a strategy to capitalise on the increasing value of its medical data.
Read More
Cancer experts urge reform of paediatric cancer trial rules
Cancer experts are calling for a reform of outdated European regulations which they are argue are preventing cancer treatments from being trialled in children.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
